Investigation of diabetes-related molecular changes in embryo-endometrium crosstalk

• Published in: Gene Vol. 922; p. 148557
• Main Authors: Tan, Semih, Tan, Seçil, Tokgün, Onur, Çetin, Hülya, Tokgün, Elvan, Özdamar, Saim
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 05.09.2024
• Subjects: Animals; Calcium; cAMP; Diabetes; Diabetes Mellitus, Experimental - genetics; Diabetes Mellitus, Experimental - metabolism; Embryo Implantation - genetics; Embryo, Mammalian - metabolism; Endometrium - metabolism; Female; Implantation; Matrix metalloproteases; Matrix Metalloproteinases - genetics; Matrix Metalloproteinases - metabolism; MicroRNAs - genetics; MicroRNAs - metabolism; Pregnancy; Pregnancy in Diabetics - genetics; Pregnancy in Diabetics - metabolism; Rats; Rats, Sprague-Dawley; Signal Transduction; Tissue Inhibitor of Metalloproteinase-1 - genetics; Tissue Inhibitor of Metalloproteinase-1 - metabolism; Pregnancy; MMP; Matrix metalloproteases; Calcium; RT-PCR; GO; KEGG; Implantation; Diabetes; cAMP; TIMP
• ISSN: 0378-1119; 1879-0038
• DOI: 10.1016/j.gene.2024.148557

•Diabetes causes MMP and TIMP expression changes.•Diabetes affects maintenance of pregnancy by calcium, BMP, p53, Hippo, Wnt and TNF like signalling pathways•Diabetes may affect these gene expressions indirectly, rather than directly, through the physiological mechanisms it causes to change. The primary aim of this study was to explore the impact of diabetes on matrix metalloproteases and tissue inhibitors, crucial factors for successful implantation, and to elucidate the molecular mechanisms that undergo changes in the endometrium and the embryo during diabetic pregnancies. In this investigation, we established a streptozotocin-induced diabetic pregnant rat model. Microarray analysis followed by RT-PCR was utilized to identify gene regions exhibiting expression alterations. Subsequently, we assessed the effects of MMPs and tissue inhibitors using ELISA and immunohistochemistry techniques, in addition to analyzing changes at the genetic level. Diabetes led to the upregulation of MMP3, MMP9, and MMP20 on the 6.5th day of pregnancy, while causing the downregulation of MMP3, MMP9, and MMP11 on the 8.5th day of pregnancy. TIMP1 expression was downregulated on the 8.5th day compared to the control group. No statistically significant differences were observed between the groups regarding other TIMP expressions. KEGG pathway analysis revealed that diabetes induced alterations in the expression of genes associated with certain microRNAs, as well as signaling pathways such as cAMP, calcium, BMP, p53, MAPK, PI3K-Akt, Jak-STAT, Hippo, Wnt, and TNF. Additionally, gene ontology analysis unveiled changes in membrane structures, extracellular matrix, signaling pathways, ion binding, protein binding, cell adhesion molecule binding, and receptor-ligand activity. This study serves as a valuable guide for investigating the mechanisms responsible for complications in diabetic pregnancies. By revealing the early-stage effects of diabetes, it offers insight into the development of new diagnostic and treatment approaches, ultimately contributing to improved patient care.